|
|
|
|
LEADER |
01840nmm a2200289 u 4500 |
001 |
EB000633211 |
003 |
EBX01000000000000000486293 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
140122 ||| eng |
020 |
|
|
|a 9781489912367
|
100 |
1 |
|
|a Pearlman, Rodney
|e [editor]
|
245 |
0 |
0 |
|a Stability and Characterization of Protein and Peptide Drugs
|h Elektronische Ressource
|b Case Histories
|c edited by Rodney Pearlman, Y. John Wang
|
250 |
|
|
|a 1st ed. 1993
|
260 |
|
|
|a New York, NY
|b Springer US
|c 1993, 1993
|
300 |
|
|
|a XXII, 353 p
|b online resource
|
505 |
0 |
|
|a 1 Stability and Characterization of Human Growth Hormone -- 2 Characterization and Formulation Considerations for Recombinantly Derived Bovine Somatotropin -- 3 Stability Characterization and Formulation Development of Alteplase, a Recombinant Tissue Plasminogen Activator -- 4 Orthoclone OKT3: Chemical Mechanisms and Functional Effects of Degradation of a Therapeutic Monoclonal Antibody -- 5 Leuprolide and Other LH-RH Analogues -- 6 Stability of Adrenocorticotropic Hormone (ACTH) and Pathways of Deamidation of Asparaginyl Residue in Hexapeptide Segments -- 7 Stability and Characterization of Human Interleukin-1? -- 8 Development and Shelf-Life Determination of Recombinant Interleukin-2 (Proleukin) -- 9 Formulation and Stability of Recombinant ?1-Antitrypsin -- 10 Fibrolase: A Fibrinolytic Protein from Snake Venom -- 11 Insulin Structure and Stability
|
653 |
|
|
|a Pharmacy
|
653 |
|
|
|a Biochemistry
|
653 |
|
|
|a Pharmacology
|
700 |
1 |
|
|a Wang, Y. John
|e [editor]
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
490 |
0 |
|
|a Pharmaceutical Biotechnology
|
028 |
5 |
0 |
|a 10.1007/978-1-4899-1236-7
|
856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-4899-1236-7?nosfx=y
|x Verlag
|3 Volltext
|
082 |
0 |
|
|a 615
|